Last reviewed · How we verify

NCT05623566

Evaluation of a Smartphone Based Screening Tool for Neonatal Jaundice in Surabaya, Indonesia

Terminated NA Last updated 4 April 2024
What this trial tests

NA trial testing Picterus Jaundice Pro in Jaundice, Neonatal in 284 participants. Terminated before completion.

Timeline
29 November 2018
Primary endpoint
29 November 2018
29 April 2019

Quick facts

Lead sponsorPicterus AS
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposescreening
Enrollment284
Start date29 November 2018
Primary completion29 November 2018
Estimated completion29 April 2019
Sites3 locations across Indonesia

Drugs / interventions tested

Conditions studied

Sponsor

Picterus AS

Who can join

Adults 1 Hour to 14 Days, any sex, with Jaundice, Neonatal. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A cross-sectional conductive study aiming to evaluate the accuracy of a novel smartphone application that estimates bilirubin levels in newborns in Surabaya.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Picterus Jaundice Pro

Trials testing the same drug.

Other recruiting trials for Jaundice, Neonatal

Currently open trials in the same condition.

Other Picterus AS trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05623566.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing